Overview
- Editors:
-
-
Laurence Klotz
-
University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada
- Profiles the new grading system for prostate cancer introduced in 2015
- Fully updated and revised new edition
- Authored by recognized experts in their respective fields
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (21 chapters)
-
-
-
- Peter Ka-Fung Chiu, Monique J. Roobol
Pages 9-20
-
-
-
- Angelo M. De Marzo, Jonathan I. Epstein
Pages 41-52
-
- Jan F. M. Verbeek, Monique J. Roobol, Ewout W. Steyerberg
Pages 53-64
-
-
- Frank-Jan H. Drost, Monique J. Roobol, Leonard P. Bokhorst
Pages 71-81
-
- Tuomas Mirtti, Hanna Vasarainen, Antti Rannikko
Pages 83-94
-
- Ivo G. Schoots, Theo H. van der Kwast
Pages 95-109
-
- Francesco Giganti, Vasilis Stavrinides, Caroline M. Moore
Pages 111-119
-
- Chad A. Reichard, Eric A. Klein
Pages 121-133
-
- Sophie M. Bruinsma, Daan Nieboer, Tim Hulsen, Liying Zhang, Rachelle Kirk-Burnnand, Sam Gledhill et al.
Pages 135-147
-
- Lara Bellardita, Paola Dordoni, Letizia De Luca, Julia Paola Menichetti Delor, Riccardo Valdagni
Pages 149-167
-
- Lionne D. F. Venderbos, Stephanie D. Brandhof, Ida J. Korfage
Pages 169-181
-
- Stacey A. Kenfield, David Tat, June M. Chan
Pages 183-198
-
-
- Jeffrey J. Tosoian, Ridwan Alam, Abbey Lepor, Stacy Loeb
Pages 207-216
-
- Juan Gómez Rivas, Mark Emberton
Pages 217-227
About this book
This fully updated and revised new edition provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in prostate cancer. The book reviews new data about molecular characteristics of the disease, profiles the new grading system for prostate cancer introduced in 2015, and provides new perspectives about imaging of prostate cancer, as well as the role of targeted biopsies. The text summarizes the role of biomarkers and MRI in patient selection and management and details the world wide results of active surveillance. Specific chapters address communication and ethical issues, QOL outcomes, economic aspects, and psycho-social aspects of surveillance. The role of focal therapy for low risk disease is summarized, and the data supporting preventive interventions during surveillance reviewed. This text will serve as a very useful resource for physicians and researchers dealing with,and interested in this common malignancy, as it provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts.
Reviews
“This is the second edition of a comprehensive review of the role of active surveillance in management of patients with localized prostate cancer. … The book is invaluable for any urologists managing patients with prostate cancer. It is extremely helpful in understanding the concept, applications, and various challenges in managing patients placed on active surveillance. … This book is a necessary part of any practicing urologist’s library.” (Mohamed T. Ismail, Doody's Book Reviews, January, 2018)
Editors and Affiliations
-
University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada
Laurence Klotz
About the editor
Laurence Klotz, MD, FRCSC, CM
Professor of Surgery, University of Toronto
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
